(1 - 30 von 36
)
Evotec berichtet Geschäftszahlen für das Jahr 2007, Evotec AG ...
www.pressebox.de
Euro für Forschungsprojekte im Frühstadium, die mit Evotec Neurosciences übernommen und aus ... erklärte Jörn Aldag, Vorstandsvorsitzender der Evotec AG. › boxid
Evotec OAI AG . Jahresabschluss Solides Wachstum trotz ...
www.openpr.de
Jörn Aldag, Vorstandsvorsitzender von Evotec OAI, kommentiert: Dr. John Kemp zum Vorsitzenden der Geschäftsführung von Evotec Neurosciences GmbH, ... › ... › Evotec
Sonderausgabe-Biotechnologie GoingPublic.de
www.goingpublic.de
Erfolgreicher? EVOTEC BioSystems: Expansion im Dienste von Big Pharma ... Life Science Ventures GmbH Jörn Aldag, EVOTEC BioSystems AG Dr. Daniel Perrissoud, ... › uploads › epaper
Allianz zwischen Evotec und Boehringer Ingelheim
www.pressetext.com
Evotec OAI AG (Deutsche Börse: EVT, TecDAX 30), Evotec Neurosciences GmbH und Boehringer Ingelheim ... Jörn Aldag, Vorstandsvorsitzender von Evotec OAI und ... › news
HOOK.A - | Stock Price & Latest News | Reuters
www.reuters.com
Joern Aldag: Chief Executive Officer, Director. Reinhard Kandera: Chief Financial Officer, Director. Christine D. Baker: Chief Operating Officer. › companies
Gentherapien: Die nächste Phase der Biotechbranche...
www.faz.net
„Wir haben noch keine Verhandlungen darüber geführt“, schränkt Jörn Aldag ein. „Aber der Preis wird in einer anderen Dimension liegen als gewöhnlich.
Evotec zuversichtlich für stelliger Mio-Euro-Betrag von ...
www.handelsblatt.com
18 Oct — ... bezifferte Jörn Aldag, Vorstandsvorsitzender von Evotec OAI und Aufsichtsratsvorsitzender von Evotec Neurosciences im Gespräch mit ... › archiv
EVOTEC : Announces Financial Results for | MarketScreener
www.marketscreener.com
Neurosciences that have been discontinued for strategic ... further develop our pipeline," said Jörn Aldag, President & CEO of. Evotec AG. › ... › Evotec SE › News
EVOTEC OAI: Appointment of new Chief Executive Officer
www.evotec.com
With effect from June 30, 2001, Jörn Aldag, the group's Chief Financial Officer, will become President and Chief Executive Officer of Evotec OAI. › investor-relations › news › e...
Evotec - Der Biotechnologie Dienstleister - Seite 3 - Deutschland ...
www.wertpapier-forum.de
So habe das Unternehmen nach der Reintegration von Evotec-Neurosciences den Umbau ... Jörn Aldag, Vorstandschef von Evotec, habe gegenüber den Experten der ... › p...
Evotec Acquires ENS and Secures €47m in Cash to Develop ...
www.evotec.com
20 Dec — Commenting on today's announcement, Joern Aldag, President and CEO of ... Evotec Neurosciences (ENS) is an innovative biotechnology company ... › investor-relations › news › e...
Evotec Neurosciences Completes € 25 Million Series A ...
www.evotec.com
Hamburg, Germany - Evotec Neurosciences (ENS), a subsidiary of Evotec OAI AG ... in the longer term" said Joern Aldag, President and CEO of Evotec OAI. › investor-relations › news › e...
Evotec Neurosciences and Evotec OAI Enter into Joint Drug ...
www.evotec.com
20 Dec — Joern Aldag, Chief Executive Officer at Evotec OAI and Chairman of the Board of Evotec Neurosciences, said: "We are delighted that ... › investor-relations › news › e...
Evotec Neurosciences and Takeda enter into drug discovery ...
test.pharmabiz.com
Evotec Neurosciences GmbH (ENS), a subsidiary of Evotec OAI and Takeda Chemical ... said Joern Aldag, President and Chief Executive Officer of Evotec OAI. › news › evotec-neuroscience...
Evotec OAI Announces Key Management Appointments To ...
www.evotec.com
20 Nov — Joern Aldag, President and Chief Executive Officer of Evotec OAI, said: "Evotec OAI owes a great deal to Mario's operational leadership and ... › investor-relations › news › e...
New CEO to Steer Hookipa Development - Labmate Online
www.labmate-online.com
Hookipa Biotech, which is pioneering a new class of immunotherapies and vaccines, has announced the appointment of Mr. Jörn Aldag as CEO, ... › ...
Tale of two biotech stars - Science|Business
sciencebusiness.net
That was the question posed by two of Europe's leading healthcare biotech pioneers, Joern Aldag of uniQure of the Netherlands and Edwin Moses of Belgium's ... › news
Bristol-Myers Squibb and uniQure Enter into Exclusive ...
news.bms.com
— ... the full breadth and capacity of our platform for cardiovascular diseases,” said Joern Aldag, Chief Executive Officer of uniQure. › details › Br...
EMA recommends first new gene therapy | Pharmafile
www.pharmafile.com
— ... final approval from the European Commission within three months after the CHMP decision,” says Jörn Aldag, chief executive of uniQure. › news
Evotec Posts Increased Revenues in Q4 - GenomeWeb
www.genomeweb.com
29 Mar — ... is [as] we have said before ... no longer core to Evotec OAI, CEO Joern Aldag said in a conference call to investors. › cbanews › evotec-posts-in...
Evotec SE Ad hoc-Service: EVOTEC BioSystems AG english
www.eqs-news.com
— With effect from June 30, 2001, Jörn Aldag, the group's Chief Financial Officer, will become President and Chief Executive Officer of Evotec ... › news
Evotec sells off chemical development business in UK to Aptuit
www.pharmatimes.com
— Explaining the rationale behind the deal, Evotec chief executive Joern Aldag said that the sale will allow it “to focus even more on its ... › ev...
Evotec to Acquire Renovis, Seek NASDAQ Listing
www.technologynetworks.com
24 Dec — Evotec AG and Renovis, Inc. today announced that they have entered ... said Jörn Aldag, President & Chief Executive Officer of Evotec AG. 19 Mar — Evotec and Boehringer Ingelheim Enter into Target Discovery ... said Joern Aldag, President and Chief Executive Officer of Evotec. › News › ... › News
FDA accepts HOOKIPA's IND application for HB-300 for the ...
www.manufacturingchemist.com
— ... oncology pipeline and arenavirus platform from viral antigens to self-antigens,” said Joern Aldag, Chief Executive Officer at HOOKIPA. › ...
sortiert nach Relevanz / Datum